News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

REVA Medical Inc. Announces Dr. David Muller as Co-Principal Investigator for RESTORE II Clinical Trial


9/13/2012 9:34:27 AM

SAN DIEGO, Sept. 12, 2012 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce the appointment of Dr. David Muller, Director, Cardiac Catheterization at St. Vincent's Hospital, Sydney, as co-principal investigator for the Company's upcoming RESTORE II clinical trial, which is expected to begin enrolling patients in the first quarter of 2013. Dr. Alexandre Abizaid of Dante Pazzanese Institute of Cardiology, who successfully led REVA's initial RESTORE pilot study, will continue as a co-principal investigator with Dr. Muller for the RESTORE II trial.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES